# Drug Interaction Study Between GSK1349572 and Tipranavir/Ritonavir in Healthy Volunteers

> **NCT01068925** · PHASE1 · COMPLETED · sponsor: **ViiV Healthcare** · enrollment: 18 (actual)

## Conditions studied

- Infection, Human Immunodeficiency Virus
- HIV Infections

## Interventions

- **DRUG:** GSK1349572

## Key facts

- **NCT ID:** NCT01068925
- **Lead sponsor:** ViiV Healthcare
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02-15
- **Primary completion:** 2010-04-05
- **Final completion:** 2010-04-05
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2019-06-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01068925

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01068925, "Drug Interaction Study Between GSK1349572 and Tipranavir/Ritonavir in Healthy Volunteers". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01068925. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*